uniQure
QURE
$4.56
Share price
-4.00%
Change (1 day)
-76.88%
Change (1 year)
uniQure (QURE) - Net assets
Net assets on the balance sheet as of December 2023 : $0.20 B
According to uniQure's latest financial reports the company has $0.20 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
uniQure - Net assets on balance sheet (from 2012 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.20 B | -56.37% |
| 2022-12-31 | $0.47 B | -20.1% |
| 2021-12-31 | $0.59 B | 144.27% |
| 2020-12-31 | $0.24 B | -24.5% |
| 2019-12-31 | $0.32 B | 79.87% |
| 2018-12-31 | $0.17 B | 100.99% |
| 2017-12-31 | $89.35 M | 40.43% |
| 2016-12-31 | $63.63 M | -50.26% |
| 2015-12-31 | $0.12 B | 144.18% |
| 2014-12-31 | $52.39 M | 581.89% |
| 2013-12-31 | $7.68 M | -1396.78% |
| 2012-12-31 | $-0.6 M | -82.37% |
| 2011-12-31 | $-3.37 M | -118.5% |
| 2010-12-31 | $18.16 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $6.23 B | 2,900.91% | 🇺🇸 USA |
 Sanofi SNY | $82.20 B | 39,483.67% | 🇫🇷 France |
 Sangamo Therapeutics
SGMO | $82.88 M | -60.09% | 🇺🇸 USA |
 bluebird bio
BLUE | $0.22 B | 7.16% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $4.95 B | 2,284.34% | 🇺🇸 USA |
 Avidity Biosciences RNA | $0.50 B | 141.13% | 🇺🇸 USA |